Melexis N.V.
MLXSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -3.3% | 15.3% | 29.9% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 43% | 45.7% | 44.8% | 42.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | -$0 | -$0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 23.6% | 27.1% | 27.1% | 23.1% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 18.4% | 21.7% | 23.6% | 20.4% |
| EPS | 4.24 | 5.18 | 4.88 | 3.25 |
| % Growth | -18.1% | 6.1% | 50.2% | – |
| EPS Diluted | 4.24 | 5.18 | 4.88 | 3.25 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 28.5% | 31.6% | 32.3% | 29.9% |